TRT For Anti-Aging: Does It Work Or Is It All Hype?

TRT for anti-aging is one of the most searched topics in men's health. The gap between marketing claims and clinical evidence is wide. Testosterone replacement therapy is FDA-approved only for men with diagnosed hypogonadism, not for age-related decline in testosterone alone (FDA, 2025). A credentialed telehealth provider offering testosterone therapy should approach treatment through lab-confirmed diagnosis, not anti-aging promises.

TRT is a prescription treatment for testosterone deficiency caused by a medical condition (hypogonadism). It is not FDA-approved for reversing normal age-related testosterone decline, and using it for that purpose carries documented risks without established benefit.

What Is Testosterone and What Role Does It Play?

Testosterone is a steroid hormone produced primarily in the testes. It plays a role in muscle mass, bone mineral density, fat distribution, red blood cell production, libido, and sperm production (Bhasin et al., 2018).

Not all circulating testosterone is active. A small fraction circulates as free testosterone, the portion available to tissues, while the rest binds to sex hormone-binding globulin (SHBG) and albumin. SHBG levels tend to rise with age, which can reduce bioavailable testosterone even when total levels appear borderline.

How Do Testosterone Levels Change with Age?

Testosterone levels peak in early adulthood and decline gradually beginning in the third decade of life, according to the Endocrine Society (Bhasin et al., 2018). This gradual decline alone doesn't meet the clinical definition of hypogonadism.

Hypogonadism requires two separate early-morning blood draws showing total testosterone consistently below guideline-recommended thresholds, combined with clinical symptoms (Mulhall et al., 2018). A low number without symptoms, or symptoms without confirmed low levels, doesn't qualify for diagnosis. The condition may stem from testicular dysfunction (primary) or pituitary/hypothalamic signaling problems (secondary). Additional labs, including LH, FSH, and prolactin, help distinguish between the two. A Marek Health testosterone FAQ covers the diagnostic process in more detail.

Can Symptoms of Aging Be Linked to Low Testosterone?

Some overlap exists. Reduced libido, erectile dysfunction, fatigue, increased body fat, decreased muscle mass, depressed mood, and difficulty concentrating are all associated with low testosterone. But these same symptoms appear in obstructive sleep apnea, thyroid disorders, type 2 diabetes, depression, and medication side effects.

That overlap is why lab confirmation is required before attributing symptoms to testosterone deficiency. Treating the wrong condition may not resolve symptoms and may add unnecessary risk. Understanding how testosterone and estradiol interact can also clarify whether a hormonal imbalance is driving specific symptoms.

Is TRT an Effective Anti-Aging Treatment?

No. The FDA retained its Limitation of Use statement in the February 2025 labeling update, specifying that testosterone products are not approved for low testosterone due solely to aging (FDA, 2025).

For men with diagnosed hypogonadism, clinical trial data supports treatment in certain domains. The TRAVERSE trial (5,246 men, ages 45-80) found that transdermal testosterone gel was noninferior to placebo for major adverse cardiovascular events, with a hazard ratio of 0.96 (95% CI, 0.78-1.17) (Lincoff et al., 2023). That trial also reported higher rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. These secondary signals prevent any blanket safety claims. Multiple TRT delivery methods exist, and the choice between them depends on individual risk factors and clinical response.

What Are the Risks of TRT?

The February 2025 FDA labeling update removed the prior cardiovascular boxed warning but added a new warning about blood pressure increases based on ambulatory monitoring data (FDA, 2025).

Other documented risks include erythrocytosis (elevated hematocrit, which may prompt dose adjustment per clinical guidelines), worsening of obstructive sleep apnea, acne, gynecomastia, and suppression of spermatogenesis (Bhasin et al., 2018). Fertility effects are variable and not guaranteed to be permanent, but suppression is common during treatment. Patients considering TRT should discuss fertility preservation before starting. Regular estradiol monitoring is part of responsible management, since testosterone can convert to estradiol through aromatization.

When Is It Appropriate to Discuss TRT with a Provider?

Men experiencing symptoms consistent with testosterone deficiency, confirmed by repeat morning lab work showing levels below guideline-recommended thresholds, are candidates for clinical evaluation. A provider will also assess cardiovascular risk, hematocrit, PSA, blood pressure, and fertility goals before initiating treatment. Treatment decisions are best made through individualized discussion between patient and provider, weighing personal risk factors and goals.

TRT for anti-aging, without a confirmed deficiency, falls outside clinical guideline recommendations and carries risk without established benefit. For men who do qualify, the choice between testosterone formulations depends on individual factors. The goal isn't chasing a number. It's treating a diagnosed deficiency under medical supervision.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

Does TRT for anti-aging increase cardiovascular risk? 

The TRAVERSE trial (Lincoff et al., 2023) found that transdermal testosterone was noninferior to placebo for major adverse cardiovascular events, with a hazard ratio of 0.96. The FDA removed the prior cardiovascular boxed warning in February 2025 but added a blood pressure warning. Individual cardiovascular risk assessment is still required before starting therapy.

How is low testosterone diagnosed? 

Diagnosis requires two separate early-morning blood draws showing total testosterone consistently below guideline-recommended thresholds, paired with clinical symptoms such as reduced libido, fatigue, or erectile dysfunction (Mulhall et al., 2018). A single test doesn't confirm deficiency, and symptoms alone don't qualify without lab confirmation.

Is TRT for anti-aging FDA-approved? 

No. The FDA's Limitation of Use statement, retained in the February 2025 labeling update, specifies that testosterone products are not approved for men whose low testosterone is due solely to aging (FDA, 2025). TRT is approved only for hypogonadism caused by a medical condition.

Does TRT affect fertility? 

Exogenous testosterone can suppress sperm production, and the degree of suppression varies by individual. Effects are not guaranteed to be permanent, but recovery isn't guaranteed either (Bhasin et al., 2018). Fertility preservation options should be discussed before starting treatment.

What monitoring is required during TRT? 

Clinical guidelines recommend periodic monitoring of hematocrit, PSA, blood pressure, estradiol, and lipids (Bhasin et al., 2018). Elevated hematocrit may prompt dose adjustment or therapeutic phlebotomy. Follow-up lab schedules are determined by the treating provider.

What forms of TRT are available? 

Testosterone replacement is available as intramuscular injections (cypionate, enanthate), transdermal gels or creams, patches, pellets, and oral formulations. Each has a different pharmacokinetic profile, convenience factor, and side-effect consideration. The choice depends on clinical evaluation and patient preference.

References

• J Clin Endocrinol Metab. 2018;103(5):1715-1744

• N Engl J Med. 2023;389:107-117

• J Urol. 2018;200(2):423-432

• FDA Drug Safety Communication: FDA Issues Class-Wide Labeling Changes for Testosterone Products. February 28, 2025.